Synonyms: EZM-0414
Compound class:
Synthetic organic
Comment: EZM0414 is a first-in-class, oral SETD2 histone methyl transferase inhibitor that was developed by Epizyme for anti-cancer potential. Its chemical structure was disclosed at the AACR spring meeting in 2022 (link to download poster pdf here).
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
N-[(1R,3S)-3-(4-acetylpiperazin-1-yl)cyclohexyl]-7-fluoro-4-methyl-1H-indole-2-carboxamide |
Synonyms ![]() |
EZM-0414 |
Database Links ![]() |
|
GtoPdb PubChem SID | 464244103 |
PubChem CID | 163196420 |
Search Google for chemical match using the InChIKey | ZGFOQXUCQAEQHH-SJORKVTESA-N |
Search Google for chemicals with the same backbone | ZGFOQXUCQAEQHH |
UniChem Compound Search for chemical match using the InChIKey | ZGFOQXUCQAEQHH-SJORKVTESA-N |
UniChem Connectivity Search for chemical match using the InChIKey | ZGFOQXUCQAEQHH-SJORKVTESA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖